HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Native and synthetic scaffolds for limbal epithelial stem cell transplantation.

Abstract
Limbal stem cell deficiency (LSCD) is a complex blinding disease of the cornea, which cannot be treated with conventional corneal transplants. Instead, a stem cell (SC) graft is required to replenish the limbal epithelial stem cell (LESC) reservoir, which is ultimately responsible for regenerating the corneal epithelium. Current therapies utilize limbal tissue biopsies that harbor LESCs as well as tissue culture expanded cells. Typically, this tissue is placed on a scaffold that supports the formation of corneal epithelial cell sheets, which are then transferred to diseased eyes. A wide range of biological and synthetic materials have been identified as carrier substrates for LESC, some of which have been used in the clinic, including amniotic membrane, fibrin, and silicon hydrogel contact lenses, each with their own advantages and limitations. This review will provide a brief background of LSCD, focusing on bio-scaffolds that have been utilized in limbal stem cell transplantation (LSCT) and materials that are being developed as potentially novel therapeutics for patients with this disease.
STATEMENT OF SIGNIFICANCE:
The outcome of patients with corneal blindness that receive stem cell grafts to restore eye health and correct vision varies considerably and may be due to the different biological and synthetic scaffolds used to deliver these cells to the ocular surface. This review will highlight the positive attributes and limitations of the myriad of carriers developed for clinical use as well as those that are being trialled in pre-clinical models. The overall focus is on developing a standardized therapy for patients, however due to the multiple causes of corneal blindness, a personal regenerative medicine approach may be the best option.
AuthorsKim N Nguyen, Samantha Bobba, Alexander Richardson, Mijeong Park, Stephanie L Watson, Denis Wakefield, Nick Di Girolamo
JournalActa biomaterialia (Acta Biomater) Vol. 65 Pg. 21-35 (Jan 2018) ISSN: 1878-7568 [Electronic] England
PMID29107055 (Publication Type: Journal Article, Review)
CopyrightCopyright © 2017 Acta Materialia Inc. Published by Elsevier Ltd. All rights reserved.
Chemical References
  • Biocompatible Materials
Topics
  • Animals
  • Biocompatible Materials
  • Blindness (physiopathology, therapy)
  • Corneal Diseases (physiopathology, therapy)
  • Epithelial Cells (cytology)
  • Humans
  • Limbus Corneae (metabolism, pathology)
  • Mice
  • Stem Cell Transplantation
  • Tissue Engineering
  • Tissue Scaffolds

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: